Dr. Cingolani is an Associate Professor at The Johns Hopkins University School of Medicine, Division of Cardiology. He earned his medical degree from Universidad Nacional de La Plata, Argentina, and completed his Internship and Internal Medicine Residency at CEMIC, Buenos Aires, Argentina, and hypertension research post-doctoral fellowship at Henry Ford Hospital, Detroit, MI. After completing his Internal Medicine Residency at The Reading Hospital and Medical Center in Pennsylvania, Dr. Cingolani joined The Johns Hopkins Hospital as a Cardiology fellow, where he remained in the Faculty after his training. Currently, he is the Associate Director of The Johns Hopkins Hospital Coronary Care Unit, Director of the Hypertension Center and member of the Echocardiography Lab and Outpatient Cardiology Clinic. He also teaches pathophysiology to medical students. Dr. Cingolani’s research interests focus on hypertensive heart disease and its transition to heart failure. He aims to elucidate the mechanism/s by which certain matricellular proteins present in the heart seem to play a protective role. His research is mainly supported by the National Institute of Health (NIH). He is also the principal investigator of the DREAM study group, studying the effect of Melatonin in preventing atrial fibrillation in patients undergoing cardiac surgery. Dr. Cingolani has been recognized by the Council for High Blood Pressure Research of the American Heart Association for his work in hypertension and is the 2011 recipient of the PJ Schafer Memorial Heart Research Award, the 2012 Michel Mirowski Discovery Fund Award, and 2013 Magic that matters Fund. Dr. Cingolani is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Multifocal Atrial Tachycardia, Cardiac Ablation, and Tissue Biopsy.

Tara Hebert, M.D., practices internal medicine at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Johns Hopkins University School of Medicine, and also completed her residency in internal medicine at Johns Hopkins Medicine School of Medicine. Dr. Hebert is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. Her top areas of expertise are Maturity Onset Diabetes of the Young, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

David Eisenberg, M.D., practices internal medicine at Johns Hopkins Community Physicians Remington. He received his medical degree from Chicago Medical School, and also completed his residency in internal medicine at Hahneman University Hospital. Dr. Eisenberg is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, and Maturity Onset Diabetes of the Young.

Colleen Leavitt, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians. She received her medical degree and completed her residency in medicine & pediatrics at Loyola University School of Medicine. Dr. Leavitt is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Dr. Agee is medical director for the Bayview Medical Offices. Her practice includes all aspects of primary care medicine, including prevention, pap smears and cortisone shots. Dr. Agee is from Annapolis. She attended Wake Forest University School of Medicine, in North Carolina, trained in general internal medicine at Johns Hopkins Bayview Medical Center. Dr. Agee is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. Her top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Type 2 Diabetes (T2D).

Anthony J. Harrell, M.D., practices internal medicine at Johns Hopkins Community Physicians Greater Dundalk. He received his medical degree from Meharry Medical College in Nashville, and completed his residency at Baptist Hospital in Tennessee. Dr. Harrell is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol.

Dr. Stephen D. Sisson is a professor of medicine at the Johns Hopkins University School of Medicine. Dr. Sisson’s area of clinical expertise is internal medicine. He serves as vice president of clinical operations for the Office of Johns Hopkins Physicians, and as director of the Johns Hopkins Physician Education and Assessment Center (PEAC). He is the Philip A. Tumulty Professor of Medicine. Dr. Sisson holds a B.S. in chemistry from Duke University. He earned his M.D. (Alpha Omega Alpha, with research honors) at Tufts University School of Medicine. He completed an internal medicine internship and residency at Johns Hopkins, serving as assistant chief of service for the Barker Firm. He joined the Johns Hopkins faculty in 1996. He served for 15 years as the associate director of the Osler Medical Housestaff Training Program. His research interests include community outreach, medical education and ambulatory care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Sisson is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are COVID-19, Cerebral Palsy, Acute Eosinophilic Pneumonia, and Hypereosinophilic Syndrome.

Dr. Redonda G. Miller is an associate professor of medicine at The Johns Hopkins University School of Medicine. Her areas of expertise include internal medicine and women’s health. Dr. Miller serves as president of The Johns Hopkins Hospital. She received her medical degree from Johns Hopkins with election to Alpha Omega Alpha, and took her internship and residency on the Osler Medical Service at Johns Hopkins. Before joining the faculty, she was appointed as an assistant chief of service (chief resident). She completed her M.B.A. at the Johns Hopkins Carey Business School in 2004, and prior to becoming vice president for medical affairs, she served as vice chair for clinical operations for the Department of Medicine. In this role, Dr. Miller helped oversee all aspects of clinical care for departmental faculty members. Her work included projects in safety and quality improvement, billing compliance and various clinical initiatives. Dr. Miller has focused her academic career on medical education and women’s health. She lectures widely and writes on midlife women’s health topics, including osteoporosis and menopause. Dr. Miller directs the Johns Hopkins Internal Medicine Board Review course and is a founding editor of the Johns Hopkins Internal Medicine Board Review book and DVD lecture series. She has published over 35 book chapters and manuscripts. A fellow of the American College of Physicians, Dr. Miller actively participates in the national Society of General Internal Medicine, having served on the National Meeting Program Committee, as chair of the Development Committee and, most recently, as national treasurer. Dr. Miller is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. Her top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Melorheostosis.

Dr. Bimal H. Ashar is a Professor of Clinical Medicine at the Johns Hopkins University School of Medicine. He serves as the Interim Director of the Division of General Internal Medicine, Clinical Director of the Division of General Internal Medicine, and Director of the Executive & Preventive Health Program. Named one of the “Best Doctors in America”, Dr. Ashar’s primary research interests include preventive medicine, dietary supplements and medical education, and he has authored numerous book chapters and articles on these topics. Dr. Ashar is also an editor of The Johns Hopkins Internal Medicine Board Review book and a former consulting editor for the Medical Clinics of North America. Dr. Ashar is an active member of the Society of General Internal Medicine and has served as president for the mid-Atlantic region. He is also a fellow of the American College of Physicians. He obtained his medical degree from the University of Maryland School of Medicine. He completed his residency in internal medicine at Case Western Reserve University/University Hospitals of Cleveland. He subsequently became chief resident and a faculty member at Case Western. Dr. Ashar left Cleveland in 1998 and joined the faculty in the Division of General Internal Medicine at Johns Hopkins University. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida and has active medical licenses in Maryland and Washington, D.C.. Videos 2017 Excellence in Service and Professionalism Award - Bimal Ashar, M.D., The Johns Hopkins Hospital Recent News Articles and Media Coverage Young MDs Hazy on Dietary Supplements, Wall Street Journal, May 14, 2007. Dr. Ashar is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Mevalonate Kinase Deficiency, Hypertension, Brugada Syndrome, and Postural Orthostatic Tachycardia Syndrome (POTS).

Dr. Daniel Ford is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in psychiatry and behavioral sciences and, at the Johns Hopkins Bloomberg School of Public Health, in health policy and management and in epidemiology. Dr. Ford serves as the director of the Institute for Clinical and Translational Research and the senior associate dean for clinical and translational research at the Johns Hopkins School of Medicine. Widely regarded as a pioneer in research associated with the interrelationships between mental disorders and chronic medical conditions, Dr. Ford gained international acclaim for clinical studies documenting depression as an independent risk factor for coronary heart disease and for research describing the long-term health risks related to sleep disturbances. He was chosen by the Robert Wood Johnson Foundation to direct the evaluation of its $12 million Depression in Primary Care Initiative. He also has been the principal researcher on a large training grant to develop researchers in general internal medicine. A leader in using the Internet for clinical research, Dr. Ford worked closely with Johns Hopkins personnel who developed e-IRB, an electronic process for submitting research proposals to the school of medicine’s Institutional Review Board, which oversees requests to launch clinical studies. His research interests include ways to improve the treatment of chronic diseases through information technology. He also advocates treating human research subjects as partners, ensuring that they receive sufficient thanks for their commitment and willingness to contribute to scientific progress. Dr. Ford received his M.D. from the State University of New York at Buffalo in 1982. He arrived at Hopkins that year as a medical resident and, except for a brief period as a National Institutes of Health fellow, has been on the Johns Hopkins faculty ever since. He received his master’s degree in public health from the Bloomberg School in 1986. He has published more than 120 research papers and book chapters, and was associate editor of the Journal of General Internal Medicine and a member of the editorial board of General Hospital Psychiatry. Dr. Ford is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Muscle Invasive Bladder Cancer, Agranulocytosis, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Dr. Brent Petty is a Professor of Medicine at the Johns Hopkins University School of Medicine. He holds a secondary appointment in Pharmacology and Molecular Sciences. Dr. Petty’s areas of expertise include clinical pharmacology and general internal medicine. He received his M.D. from the University of Utah. Dr. Petty’s research interests include quality improvement, antimicrobial chemotherapy, hospital-based medical practices, and internal medicine with ophthalmologic clinical trials. At Johns Hopkins, Dr. Petty serves as chair of the Pharmacy and Therapeutics Committee, the Clinical Quality Improvement Committee, the Continuity of Care Subcommittee. He co-chairs the Utilization Review Committee and the Order Set Review Committee. He is a member of the Society of General Internal Medicine. Dr. Petty is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Giant Cell Arteritis (GCA).

Dr. Sara Mixter is Assistant Professor of Medicine and Pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise are internal medicine, pediatrics, and primary care for adults with developmental disabilities and other complex childhood-onset conditions. She is the director of the Hopkins PACT (Pediatric-informed Adult Care and Transition) Clinic. Dr. Mixter is also the medical director of the Pediatric Complex Care Collaborative (PC3) for the Johns Hopkins Children’s Center. Dr. Mixter received her A.B. from Harvard College. She earned her M.D. from Harvard Medical School and M.P.H. from the Harvard School of Public Health. She completed her residency at Johns Hopkins as part of the inaugural group of trainees in the Urban Health Combined Internal Medicine-Pediatrics Residency Program. Her research interests include transitions of care for adolescents with special healthcare needs and education for residents and medical students, especially in primary care and complex care. Dr. Mixter has served as the Assistant Chief of Service for the Longcope firm of the Osler Medical Housestaff Training Program (2015-16), as well as Assistant Program Director for Ambulatory Education (2014-15). Dr. Mixter is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. Her top areas of expertise are Cerebral Palsy, Gastroparesis, Orbital Cellulitis, and Sickle Cell Disease.

Rani Hasan is an Interventional Cardiologist in Baltimore, Maryland. Dr. Hasan is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

David Kim is a Cardiologist in Baltimore,, Maryland. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, Atherosclerosis, and Coronary Heart Disease.

Rachelle Smith, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Duke University School of Medicine, and completed her residency in internal medicine and pediatrics at University of Rochester Medical Center. Videos Caring for the CommunityMeet Dr. Rachelle Smith. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. Her top areas of expertise are Maturity Onset Diabetes of the Young, Behcet Disease, Type 2 Diabetes (T2D), and Hypertension.

Stephen Gottlieb is a Cardiologist in Baltimore,, Maryland. Dr. Gottlieb is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Heart Failure, Cardiomyopathy, Apoplexy, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Robert Benitez is a Cardiologist in Baltimore, Maryland. Dr. Benitez is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Mitral Valve Regurgitation, Necrosis, Cardiogenic Shock, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Bradley Maron is a Cardiologist in Baltimore,, Maryland. Dr. Maron is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Pulmonary Hypertension, Hypertension, Heart Failure, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Amal Hassan Ahmed Awadalla, M.D., practices internal medicine at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Faculty of Medicine University of Khartoum, and completed her residency at Queens Hospital Center. Dr. Awadalla is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. Her top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Neurosarcoidosis, and Sarcoidosis.

Jesse McDermeit, M.D. is an internal medicine physician with Johns Hopkins Community Physicians. Dr. McDermeit received his medical degree from New York University School of Medicine in 2016. Following graduation, he returned to Johns Hopkins University where he previously completed his undergraduate training in public health and completed his internal medicine residency at the School of Medicine with a focus in Urban Primary Care. Dr. Mcdermeit is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid-Remediable Aldosteronism. His top areas of expertise are Schwannomatosis, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Hypertension.